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Introduction
There is lack of benchmarking data for central line asso-
ciated bloodstream infection (CLABSI) in Gulf Cooperation
Council (GCC) countries. Available data are small isolated
reports that do not cover different hospital locations.
Objectives
To estimate location-specific CLABSI rates in GCC
region and to compare such rates with published reports
of US National Healthcare Safety Network (NHSN) and
International Nosocomial Infection Control Consortium
(INICC).
Methods
CLABSI rates and central line utilization between 2008 and
2013 were calculated from aggregated CLABSI surveillance
data using NHSN methodology pooled from different ICUs
and oncology wards in 6 hospitals in three GCC countries;
Saudi Arabia, Oman, and Bahrain. Standardized infection
ratio (SIR) of CLABSI in GCC hospitals were compared
with published reports of NHSN and INICC.
Results
A total 461 CLABSI events were detected during 6 years
of surveillance covering 150,492 central line-days and
336,850 patient-days. The overall CLABSI rate was 3.1
per 1000 central line-days (95% CI 2.8-3.3) and overall
central line utilization was 0.45. The CLABSI rates
showed 40% reduction while central line utilization
showed 12% reduction towards the end of surveillance
period. CLABSI rates were highest in neonatal ICUs
(5.0) and adult oncology wards (4.8) while central line
utilization were highest in pediatric (0.86) and adult car-
diothoracic ICUs (0.80) and pediatric oncology wards
(0.76). After adjusting for differences in ICU types, the
risk of CLABSI in GCC hospitals was 146% higher than
NHSN hospitals but 33% lower than INICC hospitals.
Similar to NHSN hospitals, the majority of CLABSI
events (81%) were diagnosed by detecting recognized
pathogens in blood cultures.
Conclusion
The risk of CLABSI in ICU and oncology patients in GCC
countries is probably much higher than the US but the
risk in ICU patients is slightly lower than many developing
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